YAP/TAZ target genes follow a similar trend, confirming that TAZ is not being upregulated to balance the loss of YAP, supporting TAZ as an unlikely influence in neuroblastoma biology [51,52]. This evidence concerns the gene YAP1 and neuroblastoma.